HOME >> BIOLOGY >> NEWS
A humble aquarium fish may be the key to new therapies for birth defects

/p>

"The fact that injecting the human gene can rescue the zebrafish embryo is also an example of gene therapy that works really well, at least temporarily in the fish," adds Solnica-Krezel.

The zebrafish also makes it possible to pursue another, even more promising approach for developing a treatment for Menkes: Testing hundreds or thousands of compounds to see if any can restore proper copper-handling in Calamity mutants. If such a drug can be found, it would be a strong candidate for treating the disorder in human embryos.

"The zebrafish is the first animal model that allows us to watch the process of early vertebrate development and manipulate it. There is no reason why the same approach that we have used with copper cannot work for other nutrients as well," said Gitlin.

In fact, applying this approach to other nutrients and other types of birth defects is the goal of the Children's Discovery Institute, a major new initiative that Gitlin is heading as a joint venture between the St. Louis Children's Hospital and Washington University.


'"/>

Contact: David F. Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University
8-Aug-2006


Page: 1 2 3 4

Related biology news :

1. Newly discovered fish named after New York aquarium biologist
2. New asthma gene could lead to new therapies
3. Scientists decode RNA mystery, will help aim drug therapies
4. Genomic signatures identify targeted therapies for lung cancer
5. Existence of muscle-building stem cells points to regenerative therapies for muscular disease
6. Antibody-based therapies effective at controlling malaria
7. Preterm infants with RDS -- surfactant replacement therapies improves neonatal survival
8. UBC discovery may lead to smart therapies for breast, ovarian cancer
9. NDDO and ESMO joined by US National Cancer Institute in conferences on targeted cancer therapies
10. U of MN adult stem cell research shows promise for transplant therapies
11. Boost for new cancer therapies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: humble aquarium fish may the key new therapies for birth defects

(Date:8/18/2015)... 18, 2015  Navitas today announced that ... the Submission Content Management webinar scheduled on ... forum. Dedicated to the Implementation of Regulatory Submission ... for industry, vendors, health authorities, consultants and ... towards a standard method of implementing electronic ...
(Date:8/12/2015)... 12, 2015  New research unveiled at Black ... phones to steal users, fingerprints. Information released today ... fingerprint scanners on mobile devices, making the security ... biometrics on mobile devices, HYPR Corp. recently released ... authentication systems with strong cryptographic security. More information ...
(Date:8/6/2015)... , Aug. 6, 2015  Today, U.S. ... visit Crossmatch ™ to learn firsthand how ... protect data. Crossmatch is a world leader in ... and expertise are helping federal agencies and commercial ... security.   "The vast majority of ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2
(Date:9/3/2015)... ... 03, 2015 , ... UCLA wide receiver and Canadian decathlon ... therapy were not working so Zach decided to undergo stem cell therapy at ... precisely guided injections of bone marrow aspirate concentrate (BMAC) harvested with the BioMAC ...
(Date:9/3/2015)... BC , Sept. 3, 2015 /PRNewswire/ - bioLytical ... pleased to announce its study " Sensitivity of a ... detection is enhanced by its affinity for HIV gp41 ... of Clinical Virology.  This study highlights INSTI,s ability to ... presented their findings at the 8 th annual ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... and additive manufacturing on Sept. 17, 2015 at 9am PST. The webinar will focus ... application. More popularly known as 3D printing, additive manufacturing is a broad term that ...
(Date:9/2/2015)... Axovant Sciences Ltd. (NYSE:  AXON), a leading clinical-stage biopharmaceutical company ... at three investor conferences: , Wednesday, September 9 ... New York at the New York ... at the BioCentury NewsMakers Conference in New York ... , Thursday, September 17 at 9:30 AM at the ...
Breaking Biology Technology:UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 2UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 3bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 2bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 3Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 2Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 3Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 4Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3
Cached News: